The pan-Canadian early detection of lung cancer study
Stephen Lam , Ming-Sound Tsao , Martin Tammemagi , John Mayo
JOURNAL OF THORACIC ONCOLOGY 4 ( 9) S377 -S378
3
2009
Plasma pro-surfactant protein B and lung function decline in smokers (vol 45, pg 1037, 2015)
Janice M Leung , John Mayo , Wan Tan , C Martin Tammemagi
EUROPEAN RESPIRATORY JOURNAL 48 ( 3) 962 -962
2016
A Phase II Study of Dovitinib in Previously-Treated Malignant Pleural Mesothelioma: The Ontario Clinical Oncology Group DOVE-M Trial
Scott A Laurie , Desiree Hao , Natasha Leighl , John Goffin
JOURNAL OF THORACIC ONCOLOGY 10 ( 9) S352 -S352
2015
Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer
John Goffin , Pierre O Chappuis , Nora Wong , William D Foulkes
Journal of the National Cancer Institute 93 ( 22) 1754 -1754
41
2001
Introduction to clinical trials
John Goffin
Clinical Trials Handbook, Wiley 1 -22
9
2009
İleri Evre Küçük Hücreli Dışı Akciğer Kanserinin Tedavisinde Birinci Sıra Sistemik Kemoterapi
John Goffin , Christina Lacchetti , Peter M Ellis , Yee C Ung
Journal of Thoracic Oncology 2 ( 2) 75 -91
2010
Priority health needs for patients receiving concurrent chemotherapy and radiation for stage III non-small cell lung cancer and impact of the role of the advanced practice nurse (APN)
Lorraine Martelli-Reid , Denise Bryant-Lukosius , Andrew Arnold , Peter Ellis
JOURNAL OF THORACIC ONCOLOGY 4 ( 9) S436 -S437
2009
SPECIAL DEPARTMENTS-Correspondence-Bleomycin-Induced Lung Toxicity and Pentoxifylline
John Goffin , Harvey Kreisman , Victor Sandor
Journal of Clinical Oncology 19 ( 2) 593 -593
2001
Cost-Effectiveness of Smoking Cessation Within a Lung Cancer Screening Program in Canada
C. Gauvreau , N. Fitzgerald , W. Flanagan , S. Memon
Journal of Global Oncology 4
1
2018
Lung Cancer–Related Clinical and Economic Impacts of Achieving a 5% Smoking Prevalence Rate by 2035 in Canada
C. Gauvreau , N. Fitzgerald , S. Hussain , S. Memon
Journal of Global Oncology 4
2018
Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status
W. D. Foulkes , J. Goffin , J.-S. Brunet , L. R. Begin
Journal of the National Cancer Institute 94 ( 19) 1504 -1506
51
2002
Timing of exogenous surfactant administration in a rabbit model of acute lung injury
Y. Ito , J. Goffin , R. Veldhuizen , M. Joseph
Journal of Applied Physiology 80 ( 4) 1357 -1364
31
1996
Evaluation of exogenous surfactant treatment strategies in an adult model of acute lung injury.
J. F. Lewis , J. Goffin , P. Yue , L. A. McCaig
Journal of Applied Physiology 80 ( 4) 1156 -1164
38
1996
How advanced lung cancer patients are really treated at the population level? The Ontario, Canada experience
W.K. Evans , W. Flanagan , C. Gauvreau , P. Manivong
Annals of Oncology 29
2018
MA18.03 How in the Real World Are Lung Cancer Patients Treated? The Ontario, Canada Experience
W. Evans , W. Flanagan , C. Gauvreau , P. Manivong
Journal of Thoracic Oncology 13 ( 10)
2018
MA11.04 Platinum Doublet + Durvalumab +/- Tremelimumab in Patients with Advanced NSCLC: A CCTG Phase IB Study - IND.226
R. Juergens , P. Ellis , D. Tu , D. Hao
Journal of Thoracic Oncology 14 ( 10)
2019
OA 06.01 Costs and Cost-Effectiveness of Smoking Cessation Within an Organized CT Lung Cancer (LC) Screening Program
W. Evans , C. Gauvreau , W. Flanagan , S. Memon
Journal of Thoracic Oncology 12 ( 11) S1757 -S1758
1
2017
OA 15.01 Lung Cancer Screening: Participant Selection by Risk Model – the Pan-Canadian Study
M. Tammemägi , H. Schmidt , S. Martel , A. Mcwilliams
Journal of Thoracic Oncology 12 ( 11) S1784 -S1785
2017
MA 10.01 Durvalumab ± Tremelimumab with Platinum-Doublets in Non-Small Cell Lung Cancer: Canadian Cancer Trials Group Study IND.226
R. Juergens , D. Hao , S. Laurie , P. Ellis
Journal of Thoracic Oncology 12 ( 11)
2017
MA 20.11 Chronic Obstructive Pulmonary Disease Prevalence in a Lung Cancer Screening Population
J. Goffin , G. Pond , A. Tremblay , M. Johnston
Journal of Thoracic Oncology 12 ( 11)
2017